Literature DB >> 1626981

Paediatric cochlear implantation.

K P Gibbin.   

Abstract

Cochlear implantation may now be considered as a method of managing children with profound sensory hearing loss who do not benefit from conventional amplification. It involves a team approach with integration of many skilled individuals, as well as the child and his or her parents and family. As William House has said, in 1991, 'The future is not in the adult programme, but in the continued expansion of the children's programme'.

Entities:  

Mesh:

Year:  1992        PMID: 1626981      PMCID: PMC1793788          DOI: 10.1136/adc.67.6.669

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Perceptual abilities of children with the Nucleus 22-channel cochlear implant.

Authors:  S J Staller; R C Dowell; A L Beiter; J A Brimacombe
Journal:  Ear Hear       Date:  1991-08       Impact factor: 3.570

Review 2.  Evaluation and device programming in children.

Authors:  A L Beiter; S J Staller; R C Dowell
Journal:  Ear Hear       Date:  1991-08       Impact factor: 3.570

3.  Design of the UCH/RNID cochlear implant system.

Authors:  M J Conway; P Boyle
Journal:  J Laryngol Otol Suppl       Date:  1989

4.  Open-set minimum auditory capability scores for House and Nucleus cochlear prostheses.

Authors:  C A Mangham; S V Kuprenas
Journal:  Am J Otol       Date:  1989-07

5.  Evaluation of five different cochlear implant designs: audiologic assessment and predictors of performance.

Authors:  B J Gantz; R S Tyler; J F Knutson; G Woodworth; P Abbas; B F McCabe; J Hinrichs; N Tye-Murray; C Lansing; F Kuk
Journal:  Laryngoscope       Date:  1988-10       Impact factor: 3.325

6.  Cochlear implants. Present and future.

Authors:  W F House
Journal:  Otolaryngol Clin North Am       Date:  1986-05       Impact factor: 3.346

7.  Changes in endogenous enzymatic reactivity to DAB induced by neuronal inactivity.

Authors:  M T Wong-Riley; M M Merzenich; P A Leake
Journal:  Brain Res       Date:  1978-02-03       Impact factor: 3.252

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.